GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI)
CUSIP: 3622AW403
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common stock, par value $0.0001 per share
- Shares outstanding
- 10,989,570
- Total 13F shares
- 59,524
- Share change
- -74,861
- Total reported value
- $14,692
- Price per share
- $0.25
- Number of holders
- 6
- Value change
- -$201,167
- Number of buys
- 2
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 3622AW403?
CUSIP 3622AW403 identifies GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q3 2025
Recent filing periods for CUSIP 3622AW403:
Top shareholders of GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Albert Agro |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
172,189
|
$702,531 | — | 21 Apr 2023 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
10%
|
1,097,858
|
$241,529 | +$92,484 | 31 Dec 2025 | |
| DRW Securities, LLC |
13F
|
Company |
0.92%
|
100,612
|
$207,260 | — | 30 Sep 2025 | |
| Walter Marc Hertz |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
103,067
|
$88,956 | — | 18 Sep 2025 | |
| Marella Thorell |
3/4/5
|
Director |
—
class O/S missing
|
9,506
|
$38,784 | — | 13 Dec 2022 | |
| David Leslie Szekeres |
3/4/5
|
Director |
—
class O/S missing
|
39,897
|
$35,613 | — | 18 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.15%
|
17,000
|
$35,020 | — | 30 Sep 2025 | |
| Leanne Kelly |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
43,222
|
$29,704 | — | 18 Sep 2025 | |
| Vipin Chaturvedi |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
43,222
|
$29,704 | — | 18 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
12,372
|
$25,485 | — | 30 Sep 2025 | |
| Camilla Simpson V |
3/4/5
|
Director |
—
class O/S missing
|
23,605
|
$20,775 | — | 18 Sep 2025 | |
| David Charles Baker |
3/4/5
|
Director |
—
class O/S missing
|
23,605
|
$20,775 | — | 18 Sep 2025 | |
| Roelof Rongen |
3/4/5
|
Director |
—
class O/S missing
|
23,605
|
$20,775 | — | 18 Sep 2025 | |
| Ofir Levi |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
$20,571 | — | 14 May 2021 | |
| Penny Toren |
3/4/5
|
SVP, Regul Affairs & Prog Mgmt |
—
class O/S missing
|
25,000
|
$17,143 | — | 14 May 2021 | |
| Meenu Chhabra |
3/4/5
|
Director |
—
class O/S missing
|
15,000
|
$10,286 | — | 23 Feb 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.04%
|
4,024
|
$8,290 | — | 30 Sep 2025 | |
| Joseph E. Payne |
3/4/5
|
Director |
—
class O/S missing
|
7,500
|
$5,143 | — | 09 Jun 2022 | |
| Richard Ammer |
3/4/5
|
Director |
—
class O/S missing
|
7,500
|
$5,143 | — | 09 Jun 2022 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
211
|
$435 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
117
|
$241 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
27
|
$56 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
22
|
$45 | — | 30 Sep 2025 |
Institutional Holders of GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) as of Q4 2025
As of 31 Dec 2025,
GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,524 shares.
The largest 6 holders included
GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, StoneX Group Inc., Tower Research Capital LLC (TRC), BlackRock, Inc., and BANK OF AMERICA CORP /DE/.
This page lists
6
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
8
Q4 2025 holders
6
Holder diff
-2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.